Biotechnology news

Astellas Pharmaceuticals Enters $1.7 Billion Global Collaboration with Vir Biotechnology to advance PSMA-targeting PRO-XTEN - Pharmaceutical Executive

External page is loading, the page should display in a few seconds..

    Follow @BiotechnologyUK on Twitter!